Clinical trial
Treatment Efficacy for Drug Abuse and AIDS Prevention - 2
NCT00000211 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00000211 |
|---|---|
| Title | Treatment Efficacy for Drug Abuse and AIDS Prevention - 2 |
| Official title | Treatment Efficacy for Drug Abuse and AIDS Prevention |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Collaborators | Mclean Hospital |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cocaine-Related Disorders, Heroin Dependence |
| Intervention type | Drug |
| Interventions | Buprenorphine |
| Enrollment | 0 |
| Start date | Sep 1, 1989 |
| Primary completion | Feb 1, 1996 |
| Completion | Feb 1, 1996 |
| First posted | Sep 21, 1999 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: